LifeSpan BioSciences, Inc. announces the acquisition of Nordic MUbio

Release Date: July 8th, 2019

Seattle, Washington State, USA– June 2019 – LifeSpan BioSciences (LSBio), a leading provider of antibodies and life science research reagents is pleased to announce its acquisition of Nordic MUbio. Nordic MUbio are ISO 9001:2015 certified experts in developing antibodies targeting Cell Adhesion, Nuclear and Cytoskeletal Proteins.

The acquisition of Nordic MUbio further expands the LSBio product offering and strengthens the LSBio position as one of the fastest growing companies in the research reagent market. LSBio through its partnerships now offers a comprehensive catalogue of reagents that can be coupled with their extensive collection of IHC validated primary antibodies.

“We are very happy to be adding the Nordic MUbio product ranges, which also includes Exalpha Biologicals Inc., Gallus Immunotech & Biologo, to the LSBio portfolio” said Heather Holemon, CEO of LSBio. “Nordic MUbio’s products are of exceptionally high quality and they complement our existing portfolio perfectly”.

Nordic MUbio is commitment to quality and continuous improvement which has ensured that their catalogue has grown. Nordic MUbio acquired Exalpha Biologicals Inc which also grew their catalogue with brands such as Biologo & Gallus Immunotech Inc. This will broaden the LSBio offering of over 500,000 monoclonal and polyclonal primary antibodies to virtually every protein in the proteome. Through extensive ongoing in-house testing, more than 15,000 of the LSBio antibodies have also been identified as exceptional IHC reagents and given the IHC-plus™ brand.

About LifeSpan BioSciences

LifeSpan BioSciences was founded in 1995 by Doctors Joseph Brown and Glenna Burmer and was established as a molecular pathology company with a focus on protein localisation in diseased human tissue by IHC.

In addition to antibodies and IHC reagents, LSBio offers over 50,000 high-quality immunoassays, including sandwich ELISA (enzyme-linked immunosorbent assay) kits, competitive EIA (Enzyme Immunoassay) kits, as well as cell-based and DNA-binding ELISA kits. LSBio also offers a range of recombinant and native proteins and lysates.

LSBio offer services including custom IHC studies supported by a massive archival human tissue bank, and tissue cross-reactivity screening.

For more information, visit https://www.lsbio.com/